864
Can. J. Chem. Vol. 78, 2000
Methyl (±)-2-[propen-3-yl]-3-[(trimethylsilyl)oxy]-3-phenyl-
propanoate (45 and 46): Compounds 45 and 46 were pre-
pared with iodoester 24 (63 mg, 0.17 mmol) following the
general procedure described above. A 1:4 ratio of anti:syn
Ethyl (±)-(2S*)-2-[(2S*,3R*)-3-((1,1-dimethylethyl)dimethyl-
silyl)oxytetrahydrofuran-2-yl]-2-[propen-3-yl]-2-methylpro-
panoate (61): Compound 61 was prepared with iodoester 34
(77 mg, 0.18 mmol) following the general procedure de-
scribed above. A 7:1 ratio of anti:syn products was deter-
mined by GC and H NMR analyses of the crude isolate.
Purification by flash chromatography (5% EtOAc in hex-
1
products was determined by GC and H NMR analyses of
1
the crude isolate. Purification by flash chromatography (4%
EtOAc in hexanes) afforded a mixture of allylated products
45 and 46 as a colorless oil (38 mg, 78%). 1H NMR
(300 MHz, CDCl3) δ 45 (2S*,3S*): –0.05 (s, 9H), 1.77–1.84
(m, 1H), 2.11–2.19 (m, 1H), 3.72 (s, 3H), 4.72 (d, J =
9.6 Hz, 1H), 4.92–5.00 (m, 2H), 5.54–5.60 (m, 1H), 7.20–
7.35 (m, 5H), 46 (2R*,3S*): 0.01 (s, 9H), 2.47–2.54 (m,
2H), 2.71–2.76 (m, 1H), 3.44 (s, 3H), 4.81 (d, J = 7.9 Hz,
1H), 5.01–5.08 (m, 2H), 5.68–5.82 (m, 1H), 7.20–7.35 (m,
5H); 13C NMR (100 MHz, CDCl3) δ 45: 0.04, 33.11, 51.27,
55.10, 76.76, 116.52, 126.91, 127.44, 127.83, 128.18,
134.64, 141.92, 174.82, 46: 0.05, 32.76, 51.07, 55.19, 76.59,
116.30, 126.29, 127.44, 127.94, 135.59, 142.58, 173.31; IR
(neat) 3065, 2953, 1736, 1641, 1495, 1454, 1250, 1194,
1087, 995 cm–1; MS (FAB) 293.5 (MH, 58), 277.4 (30), 179
(100), 143 (55), 120 (12), 104 (20); HRMS calcd. for
C16H25SiO3 (MH) 293.1573, found: 293.1584 (–3.8 ppm).
anes) afforded allylated products 61 and 62 (43 mg, 70%).
1
61: Colorless oil; H NMR (400 MHz, CDCl3) δ 0.08 (s,
6H), 0.89 (s, 9H), 1.11 (s, 3H), 1.26 (t, J = 7.1 Hz, 3H),
1.74–1.80 (m, 1H), 1.85–1.94 (m, 1H), 2.14 (dd, J = 7.9,
13.5 Hz, 1H), 2.60 (dd, J = 6.6, 13.5 Hz, 1H), 3.82–3.95 (m,
3H), 4.11–4.19 (m, 2H); 4.29–4.32 (m, 1H), 5.04–5.10 (m,
2H), 5.67–5.77 (m, 1H); 13C NMR (100 MHz, CDCl3) δ –
4.82, –4.61, 14.13, 16.73, 17.68, 25.59, 36.40, 40.37, 48.82,
60.45, 66.91, 72.85, 91.26, 118.04, 133.53, 174.76; IR (neat)
2980, 1735, 1460, 1110, 830 cm–1; MS (FAB) m/z 343
(MH+, 13), 327 (16), 285 (100), 211 (29), 201 (18), 171
(12); HRMS calcd. for C18H35O4Si (MH+) m/z 343.2305,
found: 343.2290 (4.3 ppm).
Ethyl (±)-(2S*)-2-[(2S*)-tetrahydropyran-2-yl]-2-[propen-3-yl]-2-
methylpropanoate (65): Compound 65 (59 mg, 54%) was
prepared with iodoester 30 (148 mg, 0.48 mmol) following
the general procedure described above. A 27:1 ratio of
Ethyl (±)-(2S*)-2-[(2S*,3R*)-3-((1,1-dimethylethyl)dimethyl-
silyl)oxytetrahydrofuran-2-yl]-2-[propen-3-yl]-propanoate (57):
Compound 57 was prepared with iodoester 33 (30 mg,
0.08 mmol) following the general procedure described
above. A 6:1 ratio of anti:syn products was determined by
1
anti:syn products was determined by GC and H NMR anal-
yses of the crude isolate. Purification by flash chromatogra-
phy (10% EtOAc in hexanes) afforded allylated product 65
1
1
GC and H NMR analyses of the crude isolate. Purification
as a colorless oil. H NMR (400 MHz, CDCl3) δ 1.11 (s,
by flash chromatography (5% EtOAc in hexanes) afforded
allylated products 57 and 58 (19 mg, 80%). 57: Colorless
oil; 1H NMR (400 MHz, CDCl3) δ 0.11 (s, 6H), 0.92 (s, 9H),
1.27 (t, J = 7.0 Hz, 3H), 1.72–1.87 (m, 1H), 2.00–2.08 (m,
1H), 2.26–2.31 (m, 2H), 2.92–2.96 (m, 1H), 3.80–3.85 (m,
2H), 3.95–4.00 (m, 1H), 4.15–4.22 (m, 2H), 4.32–4.38 (m,
1H), 4.99–5.10 (m, 2H), 5.70–5.82 (m, 1H); 13C NMR
(100 MHz, CDCl3) δ –4.61, –4.82, 14.23, 17.79, 25.66,
33.24, 35.77, 45.62, 60.23, 66.18, 71.50, 83.63, 116.64,
134.47, 174.38; IR (neat) 2930, 2850, 1735, 1460, 1170,
1040 cm–1; MS (FAB) 329 (MH, 85), 283 (85), 169 (27).
Anal. calcd. for C17H32O4Si: C 62.15, H 9.82; found: C
61.72, H 9.61.
3H), 1.24 (t, J = 7.1 Hz, 3H), 1.27–1.57 (m, 5H), 1.85–1.89
(m, 1H), 2.07 (dd, J = 7.8, 13.5 Hz, 1H), 2.38 (dd, J = 7.2,
13.5 Hz, 1H), 3.33–3.41 (m, 1H), 3.48–3.52 (m, 1H), 3.93–
3.97 (m, 1H), 4.07–4.22 (m, 2H), 5.01–5.07 (m, 2H), 5.63–
5.69 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.11, 15.90,
23.58, 25.31, 25.97, 40.01, 50.29, 60.07, 68.86, 82.51,
117.76, 133.67, 176.03; IR (neat) 2930, 2870, 1725, 1640,
1435, 1080, 920 cm–1; MS (FAB) m/z 227 (MH+, 100), 199
(13), 185 (33), 151 (38), 135 (28); HRMS calcd. for
C13H23O3 (MH+) m/z 227.1647, found: 227.1654 (–3.0 ppm).
General procedure for the allylation of α-iodoesters in the
absence of Lewis acid (Conditions B)
To a solution of α-iodoester (1 equiv.) in hexanes (0.1 M)
at 23°C were added allyltributyltin (2 equiv) and AIBN (0.2
equiv). After being allowed to reflux, the mixture was stirred
until the reaction was judged complete by TLC.
Ethyl (±)-(2S*)-2-[(2S*)-tetrahydrofuran-2-yl]-2-[propen-3-
yl]-2-methylpropanoate (59): Compound 59 was prepared
with iodoester 28 (135 mg, 0.45 mmol) following the gen-
eral procedure described above. A 1:1 ratio of anti:syn prod-
1
ucts was determined by GC and H NMR analyses of the
Methyl (±)-(2R*,3S*)-2-[propen-3-yl]-3-benzyloxy-3-phenyl-
propanoate (44): To a solution of iodoester 13 (175 mg,
0.44 mmol) in CH2Cl2 (4.5 mL) at –78°C were added
allyltributyltin (275 FL, 0.88 mmol) and Et3B (90 µL of a
1.0 M solution in hexanes, 0.09 mmol). The reaction mixture
was stirred at –78°C with 0.2 equivalent of Et3B added each
30 min until the reaction was judged complete by TLC. A
1:10 ratio of anti:syn products was determined by GC and
1H NMR analyses of the crude isolate. Purification by flash
chromatography (5% EtOAc in hexanes) afforded allylated
crude isolate. Purification by flash chromatography (10%
EtOAc in hexanes) afforded allylated products 59 and 60
(79 mg, 82%). 59: Colorless oil; 1H NMR (400 MHz,
CDCl3) δ 1.12 (s, 3H), 1.27 (t, J = 7.1 Hz, 3H), 1.69–1.92
(m, 4H), 2.08 (dd, J = 7.7, 13.5 Hz, 1H), 2.49 (dd, J = 7.1,
13.5 Hz, 1H), 3.75–3.86 (m, 2H), 4.07–4.11 (m, 1H), 4.17
(q, J = 7.1 Hz, 2H), 5.03–5.10 (m, 2H), 5.65–5.77 (m, 1H);
13C NMR (100 MHz, CDCl3) δ 14.15, 15.97, 25.92, 26.28,
40.42, 49.96, 60.04, 68.47, 83.43, 117.84, 133.64, 175.09;
IR (neat) 2990, 1730, 1640, 1460, 1380, 1140, 1060 cm–1;
MS (FAB) m/z 213 (MH+, 100), 167 (22), 155 (26), 137
(74), 123 (30), 109 (40); HRMS calcd. for C12H21O3 m/z
(MH+) 213.1491, found: 213.1484 (3.1 ppm). Anal. calcd.
for C12H20O3: C 67.89, H 9.50; found: C 67.92, H 9.36.
1
products 43 and 44 (82 mg, 60%). 44: Colorless oil; H
NMR (400 MHz, CDCl3) δ 2.41–2.57 (m, 1H), 2.66–2.78
(m, 1H), 2.86–2.92 (m, 1H), 3.41 (s, 3H), 4.22 (d, J =
11.6 Hz, 1H), 4.44 (d, J = 11.6 Hz, 1H), 4.47 (d, J = 8.8 Hz,
2H), 4.95–5.09 (m, 2H), 5.78–5.81 (m, 1H), 7.25–7.43 (m,
© 2000 NRC Canada